Craft

Integra LifeSciences

Stock Price

$19.5

2024-10-29

Market Capitalization

$1.5 B

2024-10-29

Revenue

$1.5 B

FY, 2023

Integra LifeSciences Summary

Company Summary

Overview
Integra LifeSciences is a medical device company providing surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It offers products for dural access and repair, cerebral spinal fluid management and neuro-critical care, nerve and tendon repairs, treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery. The company serves hospitals, surgery centers, and alternate care sites, including physician and dental offices.
Type
Public
Status
Active
Founded
1989
HQ
Princeton, NJ, US | view all locations
Website
https://www.integralife.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jan de Witte

    Jan de Witte, President & Chief Executive Officer

  • Glenn G. Coleman

    Glenn G. Coleman, Executive Vice President & Chief Operating Officer

  • Carrie Anderson

    Carrie Anderson, Executive Vice President & Chief Financial Officer

  • Eric Schwartz

    Eric Schwartz, Executive Vice President, Chief Legal Officer & Secretary

Operating MetricsView all

Facility Space Leased, sq. ft.

167K

FY, 2021

Countries

130
44.4%

FY, 2021

LocationsView all

5 locations detected

  • Princeton, NJ HQ

    United States

    1100 Campus Rd

  • Memphis, TN

    United States

    7740 Trinity Rd #107, Cordova

  • Clayton, VIC

    Australia

    3/24-30 Winterton Rd

  • Shanghai, Shang Hai Shi

    China

    Unit 307, B Tower, SOHO Fuxing Plaza, Danshui Road, Huangpu District

  • Tokyo, Tokyo

    Japan

    Akasaka Enokizaka Bldg. 9F, 1-7-1 Akasaka, Minato-ku

Integra LifeSciences Financials

Summary Financials

Revenue (Q3, 2024)
$380.8M
Gross profit (Q3, 2024)
$200.2M
Net income (Q3, 2024)
($10.7M)
Cash (Q3, 2024)
$215.2M
EBIT (Q3, 2024)
($8.2M)
Enterprise value
$2.6B

Footer menu